Envestnet Asset Management
HQL

Envestnet Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Envestnet Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
+14,206
New +$237K ﹤0.01% 4431
2025
Q4 		– Sell
-10,301
Closed -$160K – 4546
2025
Q3 		$160K Sell
10,301
-1,500
-13% -$20.5K ﹤0.01% 4362
2025
Q2 		$151K Buy
11,801
+743
+7% +$9.16K ﹤0.01% 4290
2025
Q1 		$140K Buy
+11,058
New +$150K ﹤0.01% 4198

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Envestnet Asset Management's HQL Position: Q1 2026 in Review

Envestnet Asset Management opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 14,206 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #4431 among its holdings. This is a return to the name: Envestnet Asset Management previously reported a position in HQL as recently as Q3 2025.

Envestnet Asset Management first reported a position in HQL in Q1 2025 and has held it in 4 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Envestnet Asset Management held 14,206 shares of abrdn Life Sciences Investors worth $231K as of Q1 2026.
  • abrdn Life Sciences Investors was a new Envestnet Asset Management position in Q1 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #4431 holding.
  • Envestnet Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2025 and has held it in 4 quarters since.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.